TGFB1 and breast cancer: Here, we have employed nontransformed NMuMG cells and Py2T murine breast cancer cells to delineate the molecular mechanisms underlying a TGFβ-induced EMT, including overcoming TGFβ-induced resistance to apoptosis and the acquisition of invasive properties.